A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ho Jin Shin, MD
Pusan National University Hospital
Principal Investigator - Hyeon Seok Eom, MD
National Cancer Center
Principal Investigator - Hyo song Kim, MD
Severance Hosp
Principal Investigator - Jeeyun Lee, MD
Samsung Medical Center
Principal Investigator - Min-hee Ryu, MD
Asan Medical Cente
Principal Investigator - Minsuk Kwon, MD
Ajou Univ. Hosp.
Principal Investigator - Won Seog Kim, MD
Samsung Medical Center
Principal Investigator - Won Sik Lee, MD
Inje University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Samsung Medical Center
Seoul, Gangnam-gu, South Korea
Not, yet, recruiting - National Cancer Center
Goyang-si, Gyeonggi-do, South Korea
Not, yet, recruiting - Inje Univ. Hosp
Pusan, South Korea
Not, yet, recruiting - Pusan National Univ. Hosp.
Pusan, South Korea
Recruiting - Samsung Medical Center
Seoul, South Korea
Not, yet, recruiting - Seoul Asan Medical Center
Seoul, South Korea
Not, yet, recruiting - Severance Hosp.
Seoul, South Korea
Not, yet, recruiting - Ajou Univ Hosp.
Suwon, South Korea
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Dec 2018
- Primary completion
- 30 Sept 2022
- Completion
- 31 Dec 2024
- Last update posted
- 11 Jul 2022
- Registered enrollment
- 72
- Registry id
- NCT03789617
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.